Literature DB >> 7972097

Targeting of DNA polymerase to the adenovirus origin of DNA replication by interaction with nuclear factor I.

M T Armentero1, M Horwitz, N Mermod.   

Abstract

Efficient initiation by the DNA polymerase of adenovirus type 2 requires nuclear factor I (NFI), a cellular sequence-specific transcription factor. Three functions of NFI--dimerization, DNA binding, and activation of DNA replication--are colocalized within the N-terminal portion of the protein. To define more precisely the role of NFI in viral DNA replication, a series of site-directed mutations within the N-terminal domain have been generated, thus allowing the separation of all three functions contained within this region. Impairment of the dimerization function prevents sequence-specific DNA binding and in turn abolishes the NFI-mediated activation of DNA replication. NFI DNA-binding activity, although necessary, is not sufficient to activate the initiation of adenovirus replication. A distinct class of NFI mutations that abolish the recruitment of the viral DNA polymerase to the origin also prevent the activation of replication. Thus, a direct interaction of NFI with the viral DNA polymerase complex is required to form a stable and active preinitiation complex on the origin and is responsible for the activation of replication by NFI.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972097      PMCID: PMC45266          DOI: 10.1073/pnas.91.24.11537

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Eukaryotic replication origins.

Authors:  P G Held; N H Heintz
Journal:  Biochim Biophys Acta       Date:  1992-04-06

Review 2.  Eukaryotic DNA polymerases.

Authors:  T S Wang
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

3.  Regulation of DNA replication in vitro by the transcriptional activation domain of GAL4-VP16.

Authors:  L Z Cheng; J L Workman; R E Kingston; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

4.  Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator.

Authors:  I J Mohr; R Clark; S Sun; E J Androphy; P MacPherson; M R Botchan
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

5.  The adenovirus terminal protein influences binding of replication proteins and changes the origin structure.

Authors:  R Pronk; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Interactions between the adenovirus type 2 DNA polymerase and the DNA binding domain of nuclear factor I.

Authors:  J Bosher; E C Robinson; R T Hay
Journal:  New Biol       Date:  1990-12

8.  A yeast chromosomal origin of DNA replication defined by multiple functional elements.

Authors:  Y Marahrens; B Stillman
Journal:  Science       Date:  1992-02-14       Impact factor: 47.728

9.  Nuclear factor I enhances adenovirus DNA replication by increasing the stability of a preinitiation complex.

Authors:  Y M Mul; P C Van der Vliet
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

10.  Recognition of the adenovirus type 2 origin of DNA replication by the virally encoded DNA polymerase and preterminal proteins.

Authors:  S M Temperley; R T Hay
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  17 in total

Review 1.  The Nuclear Factor I (NFI) gene family in mammary gland development and function.

Authors:  Janice Murtagh; Finian Martin; Richard M Gronostajski
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

2.  Adenovirus DNA polymerase: domain organisation and interaction with preterminal protein.

Authors:  E J Parker; C H Botting; A Webster; R T Hay
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

3.  Two regions within the DNA binding domain of nuclear factor I interact with DNA and stimulate adenovirus DNA replication independently.

Authors:  J Dekker; J A van Oosterhout; P C van der Vliet
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

4.  Genetic analysis of the activation domain of bovine papillomavirus protein E2: its role in transcription and replication.

Authors:  M K Ferguson; M R Botchan
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  Domain organization of the adenovirus preterminal protein.

Authors:  A Webster; I R Leith; R T Hay
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Role of preterminal protein processing in adenovirus replication.

Authors:  A Webster; I R Leith; J Nicholson; J Hounsell; R T Hay
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Insulin represses transcription of the thyroid stimulating hormone beta-subunit gene through increased recruitment of nuclear factor I.

Authors:  Kee Kwang Kim; Key Sun Park; Seok Bean Song; Kyoon Eon Kim
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

8.  cis elements that contribute to geminivirus transcriptional regulation and the efficiency of DNA replication.

Authors:  P A Eagle; L Hanley-Bowdoin
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  DNase I hypersensitivity sites and nuclear protein binding on the fatty acid synthase gene: identification of an element with properties similar to known glucose-responsive elements.

Authors:  F Foufelle; N Lepetit; D Bosc; N Delzenne; J Morin; M Raymondjean; P Ferré
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

10.  Regulation of the DNA-binding and transcriptional activities of Xenopus laevis NFI-X by a novel C-terminal domain.

Authors:  E Roulet; M T Armentero; G Krey; B Corthésy; C Dreyer; N Mermod; W Wahli
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.